Pure Global

Human papillomavirus (HPV) nucleic acid IVD, control - UK MHRA Medical Device Registration

Human papillomavirus (HPV) nucleic acid IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 131270. The device is manufactured by LGC Clinical Diagnostics, Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is QCS International LTD..

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Human papillomavirus (HPV) nucleic acid IVD, control
MHRA Device ID: 131270โ€ขRef: 131270

Device Type

In Vitro Diagnostic Device

Devices

Human papillomavirus (HPV) nucleic acid IVD, control

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Oct 31, 2024

Manufacturer Information

Address

37 Birch Street

Milford, Massachusetts, United States

Created Date

Apr 30, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Suite 9 Cumbernauld Business Park Wardpark Road

Cumbernauld, North Lanarkshire, Scotland, United Kingdom

Postcode: G67 3JZ

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing